| Article ID | Journal | Published Year | Pages | File Type | 
|---|---|---|---|---|
| 9954872 | Biomedicine & Pharmacotherapy | 2018 | 10 Pages | 
Abstract
												DBH-AS1 facilitated the development of HCC via miR-138/FAK/Src/ERK pathway, establishing the molecular basis of DBH-AS1 in clinical application for HCC.
											Related Topics
												
													Health Sciences
													Medicine and Dentistry
													Oncology
												
											Authors
												Jie Bao, Xiaoqi Chen, Yuge Hou, Gailing Kang, Qiaoli Li, Yun Xu, 
											